In STEMI patients, a key contraindication to nitrate administration is hypotension, as nitrates can exacerbate low blood pressure. Additionally, the use of phosphodiesterase-5 inhibitors within a certain timeframe poses significant risks. Careful evaluation of these factors is essential for safe treatment outcomes. ;
The primary contraindication to nitrate administration in patients with STEMI is hypotension, as it can worsen low blood pressure. Additionally, recent use of phosphodiesterase-5 inhibitors poses a significant risk due to potential severe hypotension. Proper assessment of these factors is essential for safe treatment in emergency situations.
;